West Pharmaceutical Services, Inc.WST
NYSE•Healthcare•Medical Instruments & Supplies
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $3.22B, growing 11.2% year-over-year. TTM net income stood at $542.70M (16.2% growth). Quarterly EBITDA was $222.30M and operating income was $177.10M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze WST growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters